Prevent Nigerian Mothers from Dying in Childbirth

See all photos

Summary

A low cost, off-patent drug stops postpartum hemorrhage. Thousands of women's lives can be saved by making it available to traditional midwives through market distribution in developing countries. progress reportread updates from the field

How You Can Help  question mark

Make a donation
 

Received $27,667 from 82 donations from people like:

John
Rob
Nikos
cjin

+
YOU!
Give now to become donor #83!

Actions

Printer Friendly
Add to Favorite Projects
Add to Registry
Subscribe to Updates
Subscribe to RSS Feed

Share & Save

Spread the Word
Tag on del.icio.us
Share on Facebook

More Information About this Project

Project Needs and Beneficiaries

Each year, twice as many women die in childbirth as people who died in the 2004 tsunami. 99% of these deaths are in developing countries and hemorrhage is the most common cause worldwide. Bleeding can be controlled in a clinic, but our projects are the first to show traditional midwives can save lives in a woman’s home, where most births take place. This is also where most maternal deaths occur in the developing world--well beyond the reach of hospitals and government health services.

Activities

We sponsor clinical demonstration studies with traditional midwives; co-sponsor government policy meetings; train doctors and midwives to use misoprostol; and develop market distribution for the drug to be available in pharmacies & clinics countrwide

Funding Information

Total Funding Received to Date: $27,667
Remaining Goal to be Funded: $22,333
Total Funding Goal: $50,000

Additional Documentation

This project has provided additional documentation in a Microsoft Word file (projdoc.doc).

Resources

Why this Project is Important

Potential Long Term Impact

The project is uniquely scalable and sustainable. With this drug, traditional midwives get their first effective technology and see the first large-scale decline in mortality. Low-cost distribution will ensure widespread access.

Project Message

“My eldest daughter died of postpartum hemorrhage four years ago. In this project we are saving women’s lives with misoprostol. If we had had this earlier, we would have saved her life too.”
- Margaum, traditional midwife in our Tanzanian study

Who is Running This Project

Contact

Amy Grossman,
Project contact
Venture Strategies
2140 Shattuck Avenue, Suite 1110
Berkeley, California 94704-1234
United States
510-665-1880
Email:

Project Sponsor

Marketplace 2005

Organization

Venture Strategies for Health and Development
Venture Strategies
2140 Shattuck Avenue, Suite 1110
Berkeley, California 94704-1234
United States
510-665-1880
http://www.venturestrategies.org

Learn more about Venture Strategies for Health and Development and the project team.


Venture Strategies for Health and Development's Current Projects on GlobalGiving

Saving Mothers' Lives in Rural Tanzania
Saving Mothers' Lives in Rural Tanzania 		Teach Traditional Ethiopian Midwives to Save Lives
Teach Traditional Ethiopian Midwives to Save Lives

Where this Project is Located

Country

This project is located in Nigeria and can also be found under Health.

For more information about Nigeria, read the Human Development Report on Nigeria or the Wikipedia entry for Nigeria.

When this Project was Updated

Last Updated

This project was last updated on August 07, 2008.

Date Added to GlobalGiving

This project was added to the GlobalGiving project catalog on January 17, 2005.

Latest Update from the Field

Nigerians Approve New Misoprostol Clinical Guidelines

By Amy Grossman - Communications Manager, August 15, 2007 10:24 PM

Following our active involvement in achieving the world's first regulatory approval of misoprostol for postpartum hemorrhage, Venture Strategies for Health and Development assisted in the preparation of the misoprostol clinical guidelines for physicians and nurses in Nigeria. These guidelines were recently approved by the Nigerian Family Ministry of Health after they convened a technical expert meeting.

The inclusion of misoprostol in the country's official clinical guidelines is a fundamental step towards ensuring that misoprostol is used at the facility level to control postpartum hemorrhage - excessive bleeding after childbirth.

Dissemination and sensitization on the newly approved clinical guidelines have begun for health care professionals throughout the country. These sensitization efforts are coinciding with ongoing training efforts to familiarize health care providers with Active Management of Third Stage Labor and the Judicious use of Misoprostol and distribution activities of the local distributor, Emzor.

Links:

Read 3 more "Updates from the Field" | Comment on this update

Subscribe to "Updates from the Field" by E-Mail

How Else You Can Help

Spread the Word on your Profile, Blog, or Website

Put a widget for this project on your profile, blog or website to turn your friends into givers. Using our widget, it's quick and easy to add this widget to your profile or blog!

Get this widget on: